Judge Dismisses Tercica, Genentech Patent Suit Vs. Insmed
A federal judge has dismissed Tercica, Inc.'s and Genentech, Inc.'s patent infringement lawsuit against rival Insmed Inc. over its SomatoKine growth hormone treatment....To view the full article, register now.
Already a subscriber? Click here to view full article